Hongtao Capitals a private equity fund management firm that focuses on investments In AI, semiconductors, and biomedicine.
Hongtao Capitals a private equity fund management firm that focuses on investments In artificial intelligence, semiconductors, and biomedicine.The firm was established in Shenzhen, Guangdong.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 30, 2022
Hongxin Biology
|
Angel | — | Biopharma | Yes |
Oct 23, 2020
Sirnaomics
|
Series D | $105M | Biopharma | — |